🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test whether attention bias modification tr...
Status
Completed
Location
Department of Psychology, Hunan Normal University
Start Date
2011-09
Trial ID
NCT01628016
Treatments Being Tested
This study aims to test the efficacy and feasibility of administering a com...
Status
Completed
Location
Clinicas de Salud del Pueblo healthcare system
Start Date
2017-09-01
Trial ID
NCT03028792
Treatments Being Tested
This study examines whether a computerized attention-training intervention ...
Status
Recruiting
Location
Tel Aviv university
Start Date
2026-06-15
Trial ID
NCT07666776
Treatments Being Tested
The investigators have previously shown that safe, non-invasive methods of ...
Status
Recruiting
Location
The University of Texas at Austin
Start Date
2025-09-01
Trial ID
NCT07133893
Treatments Being Tested
This clinical trial studies how well attention bias modification (ABM) impr...
Status
Completed
Location
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Start Date
2024-11-08
Trial ID
NCT06682039
Threat-related attentional biases have been identified as a possible precur...
Status
Completed
Location
University of Nebraska-Lincoln
Start Date
2015-11
Trial ID
NCT02615717
Treatments Being Tested
Anxiety disorders are one of the most common psychological disorders. Under...
Status
Completed
Location
Northern Michigan University
Start Date
2017-12-15
Trial ID
NCT03092609
Treatments Being Tested
Background: Major depressive disorder (MDD) is a highly prevalent psychiatr...
Status
Unknown
Location
Jan Ivar Røssberg
Start Date
2022-09-22
Trial ID
NCT05503966
Treatments Being Tested
Depression has been associated with an attention bias towards negative info...
Status
Unknown
Location
The University of Texas at Tyler
Start Date
2022-10-01
Trial ID
NCT05816564
Treatments Being Tested